{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T23:24:26Z","timestamp":1767309866957,"version":"3.48.0"},"publisher-location":"Cham","reference-count":126,"publisher":"Springer Nature Switzerland","isbn-type":[{"type":"print","value":"9783032099808"},{"type":"electronic","value":"9783032099815"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1007\/82_2025_312","type":"book-chapter","created":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T12:36:45Z","timestamp":1749127005000},"page":"121-147","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["T Cell Responses During Dengue Infection"],"prefix":"10.1007","author":[{"given":"Luciana Barros","family":"de Arruda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernesto T. A.","family":"Marques","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,6]]},"reference":[{"issue":"14","key":"312_CR1","doi-asserted-by":"publisher","first-page":"1128784","DOI":"10.3389\/fimmu.2023.1128784","volume":"28","author":"C Aggarwal","year":"2023","unstructured":"Aggarwal C, Ramasamy V, Garg A, Shukla R, Khanna N (2023) Cellular T-cell immune response profiling by tetravalent dengue subunit vaccine (DSV4) candidate in mice. Front Immunol 28(14):1128784. https:\/\/doi.org\/10.3389\/fimmu.2023.1128784","journal-title":"Front Immunol"},{"issue":"2","key":"312_CR2","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.imlet.2004.07.006","volume":"95","author":"J An","year":"2004","unstructured":"An J, Zhou DS, Zhang JL, Morida H, Wang JL, Yasui K (2004) Dengue-specific CD8+ T cells have both protective and pathogenic roles in dengue virus infection. Immunol Lett 95(2):167\u2013174. https:\/\/doi.org\/10.1016\/j.imlet.2004.07.006","journal-title":"Immunol Lett"},{"issue":"5","key":"312_CR3","doi-asserted-by":"publisher","first-page":"e02147","DOI":"10.1128\/JVI.02147-16","volume":"91","author":"MA Angelo","year":"2017","unstructured":"Angelo MA, Grifoni A, O'Rourke PH, Sidney J, Paul S, Peters B, de Silva AD, Phillips E, Mallal S, Diehl SA, Kirkpatrick BD, Whitehead SS, Durbin AP, Sette A, Weiskopf D (2017) Human CD4+ T cell responses to an attenuated tetravalent dengue vaccine parallel those induced by natural infection in magnitude, HLA restriction, and antigen specificity. J Virol 91(5):e02147\u2013e02116. https:\/\/doi.org\/10.1128\/JVI.02147-16","journal-title":"J Virol"},{"key":"312_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.115366","volume":"4","author":"A Ansari","year":"2025","unstructured":"Ansari A, Sachan S, Ahuja J, Venkadesan S, Nikam B, Kumar V, Jain S, Singh BP, Coshic P, Sikka K, Wig N, Sette A, Weiskopf D, Mohanty D, Soneja M, Gupta N (2025) Distinct features of a peripheral T helper subset that drives the B cell response in dengue virus infection. Cell Rep 4:115366. https:\/\/doi.org\/10.1016\/j.celrep.2025.115366","journal-title":"Cell Rep"},{"issue":"2","key":"312_CR5","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3390\/v17020212","volume":"17","author":"G Anumanthan","year":"2025","unstructured":"Anumanthan G, Sahay B, Mergia A (2025) Current dengue virus vaccine developments and future directions. Viruses 17(2):212. https:\/\/doi.org\/10.3390\/v17020212","journal-title":"Viruses"},{"issue":"5","key":"312_CR6","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.4049\/jimmunol.176.5.2817","volume":"176","author":"HS Bashyam","year":"2006","unstructured":"Bashyam HS, Green S, Rothman AL (2006) Dengue virus-reactive CD8+ T cells display quantitative and qualitative differences in their response to variant epitopes of heterologous viral serotypes. J Immunol 176(5):2817\u20132824. https:\/\/doi.org\/10.4049\/jimmunol.176.5.2817","journal-title":"J Immunol"},{"issue":"21","key":"312_CR7","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1056\/NEJMoa1903869","volume":"381","author":"S Biswal","year":"2019","unstructured":"Biswal S, Reynales H, Saez-Llorens X, Lopez P, Borja-Tabora C, Kosalaraksa P, Sirivichayakul C, Watanaveeradej V, Rivera L, Espinoza F, Fernando L, Dietze R, Luz K, Ven\u00e2ncio da Cunha R, Jimeno J, L\u00f3pez-Medina E, Borkowski A, Brose M, Rauscher M, LeFevre I, Bizjajeva S, Bravo L, Wallace D (2019) Efficacy of a tetravalent dengue vaccine in healthy children and adolescents. N Engl J Med 381(21):2009\u20132019","journal-title":"N Engl J Med"},{"issue":"1","key":"312_CR8","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1089\/vim.2006.19.10","volume":"19","author":"JE Blaney Jr","year":"2006","unstructured":"Blaney JE Jr, Durbin AP, Murphy BR, Whitehead SS (2006) Development of a live attenuated dengue virus vaccine using reverse genetics. Viral Immunol 19(1):10\u201332. https:\/\/doi.org\/10.1089\/vim.2006.19.10","journal-title":"Viral Immunol"},{"issue":"3","key":"312_CR9","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/S1473-3099(24)00566-8","volume":"25","author":"S Bos","year":"2025","unstructured":"Bos S, Zambrana JV, Duarte E, Graber AL, Huffaker J, Montenegro C, Premkumar L, Gordon A, Kuan G, Balmaseda A, Harris E (2025) Serotype-specific epidemiological patterns of inapparent versus symptomatic primary dengue virus infections: a 17-year cohort study in Nicaragua. Lancet Infect Dis 25(3):346\u2013356. https:\/\/doi.org\/10.1016\/S1473-3099(24)00566-8","journal-title":"Lancet Infect Dis"},{"issue":"24","key":"312_CR10","doi-asserted-by":"publisher","first-page":"11259","DOI":"10.1128\/JVI.01424-16","volume":"90","author":"A Chandele","year":"2016","unstructured":"Chandele A, Sewatanon J, Gunisetty S, Singla M, Onlamoon N, Akondy RS, Kissick HT, Nayak K, Reddy ES, Kalam H, Kumar D, Verma A, Panda H, Wang S, Angkasekwinai N, Pattanapanyasat K, Chokephaibulkit K, Medigeshi GR, Lodha R, Kabra S, Ahmed R, Murali-Krishna K (2016) Characterization of human CD8 T cell responses in dengue virus-infected patients from India. J Virol 90(24):11259\u201311278. https:\/\/doi.org\/10.1128\/JVI.01424-16","journal-title":"J Virol"},{"issue":"12","key":"312_CR11","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1093\/infdis\/jir197","volume":"203","author":"AJ Chase","year":"2011","unstructured":"Chase AJ, Medina FA, Mu\u00f1oz-Jord\u00e1n JL (2011) Impairment of CD4+ T cell polarization by dengue virus-infected dendritic cells. J Infect Dis 203(12):1763\u20131774. https:\/\/doi.org\/10.1093\/infdis\/jir197","journal-title":"J Infect Dis"},{"issue":"3","key":"312_CR12","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/(sici)1096-9071(199911)59:3<335::aid-jmv13>3.0.co;2-e","volume":"59","author":"UC Chaturvedi","year":"1999","unstructured":"Chaturvedi UC, Elbishbishi EA, Agarwal R, Raghupathy R, Nagar R, Tandon R, Pacsa AS, Younis OI, Azizieh F (1999) Sequential production of cytokines by dengue virus-infected human peripheral blood leukocyte cultures. J Med Virol 59(3):335\u2013340. https:\/\/doi.org\/10.1002\/(sici)1096-9071(199911)59:3<335::aid-jmv13>3.0.co;2-e","journal-title":"J Med Virol"},{"issue":"5","key":"312_CR13","doi-asserted-by":"publisher","first-page":"730","DOI":"10.3390\/v16050730","volume":"16","author":"YM Chawla","year":"2024","unstructured":"Chawla YM, Bajpai P, Saini K, Reddy ES, Patel AK, Murali-Krishna K, Chandele A (2024) Regional variation of the CD4 and CD8 T cell epitopes conserved in circulating dengue viruses and shared with potential vaccine candidates. Viruses 16(5):730. https:\/\/doi.org\/10.3390\/v16050730","journal-title":"Viruses"},{"issue":"6","key":"312_CR14","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.immuni.2019.10.007","volume":"51","author":"MHY Chng","year":"2019","unstructured":"Chng MHY, Lim MQ, Rouers A, Becht E, Lee B, MacAry PA, Lye DC, Leo YS, Chen J, Fink K, Rivino L, Newell EW (2019) Large-scale HLA tetramer tracking of T cells during dengue infection reveals broad acute activation and differentiation into two memory cell fates. Immunity 51(6):1119\u20131135.e5. https:\/\/doi.org\/10.1016\/j.immuni.2019.10.007","journal-title":"Immunity"},{"issue":"10","key":"312_CR15","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1093\/infdis\/jiv258","volume":"212","author":"H Chu","year":"2015","unstructured":"Chu H, George SL, Stinchcomb DT, Osorio JE, Partidos CD (2015) CD8+ T-cell responses in Flavivirus-naive individuals following immunization with a live-attenuated tetravalent dengue vaccine candidate. J Infect Dis 212(10):1618\u20131628. https:\/\/doi.org\/10.1093\/infdis\/jiv258","journal-title":"J Infect Dis"},{"issue":"1","key":"312_CR16","doi-asserted-by":"publisher","first-page":"130","DOI":"10.3390\/v14010130","volume":"14","author":"E Cimini","year":"2022","unstructured":"Cimini E, Grassi G, Beccacece A, Casetti R, Castilletti C, Capobianchi MR, Nicastri E, Agrati C (2022) In acute dengue infection, high TIM-3 expression may contribute to the impairment of IFN\u03b3 production by circulating V\u03b42 T cells. Viruses 14(1):130. https:\/\/doi.org\/10.3390\/v14010130","journal-title":"Viruses"},{"issue":"4","key":"312_CR17","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.immuni.2014.10.004","volume":"41","author":"S Crotty","year":"2014","unstructured":"Crotty S (2014) T follicular helper cell differentiation, function, and roles in disease. Immunity 41(4):529\u2013542. https:\/\/doi.org\/10.1016\/j.immuni.2014.10.004","journal-title":"Immunity"},{"issue":"11","key":"312_CR18","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1038\/ni.3850","volume":"18","author":"A Culshaw","year":"2017","unstructured":"Culshaw A, Ladell K, Gras S, McLaren JE, Miners KL, Farenc C, van den Heuvel H, Gostick E, Dejnirattisai W, Wangteeraprasert A, Duangchinda T, Chotiyarnwong P, Limpitikul W, Vasanawathana S, Malasit P, Dong T, Rossjohn J, Mongkolsapaya J, Price DA, Screaton GR (2017) Germline bias dictates cross-serotype reactivity in a common dengue-virus-specific CD8+ T cell response. Nat Immunol 18(11):1228\u20131237. https:\/\/doi.org\/10.1038\/ni.3850","journal-title":"Nat Immunol"},{"issue":"2","key":"312_CR19","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.virol.2012.09.038","volume":"435","author":"TM da Concei\u00e7\u00e3o","year":"2013","unstructured":"da Concei\u00e7\u00e3o TM, Rust NM, Berbel AC, Martins NB, do Nascimento Santos CA, Da Poian AT, de Arruda LB. (2013) Essential role of RIG-I in the activation of endothelial cells by dengue virus. Virology 435(2):281\u2013292. https:\/\/doi.org\/10.1016\/j.virol.2012.09.038","journal-title":"Virology"},{"issue":"1","key":"312_CR20","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1186\/s12964-024-01779-4","volume":"22","author":"MK Dash","year":"2024","unstructured":"Dash MK, Samal S, Rout S, Behera CK, Sahu MC, Das B (2024) Immunomodulation in dengue: towards deciphering dengue severity markers. Cell Commun Signal 22(1):451. https:\/\/doi.org\/10.1186\/s12964-024-01779-4","journal-title":"Cell Commun Signal"},{"issue":"3","key":"312_CR21","doi-asserted-by":"publisher","first-page":"849","DOI":"10.4269\/ajtmh.17-0416","volume":"98","author":"JR Danko","year":"2018","unstructured":"Danko JR, Kochel T, Teneza-Mora N, Luke TC, Raviprakash K, Sun P, Simmons M, Moon JE, De La Barrera R, Martinez LJ, Thomas SJ, Kenney RT, Smith L, Porter KR (2018) Safety and immunogenicity of a tetravalent dengue DNA vaccine administered with a cationic lipid-based adjuvant in a phase 1 clinical trial. Am J Trop Med Hyg. 98(3):849\u2013856. https:\/\/doi.org\/10.4269\/ajtmh.17-0416","journal-title":"Am J Trop Med Hyg."},{"issue":"6888","key":"312_CR22","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/s0140-6736(55)93328-6","volume":"269","author":"FM Davenport","year":"1955","unstructured":"Davenport FM, Hennessy AV, Stuart-Harris CH, Francis T Jr (1955) Epidemiology of influenza; comparative serological observations in England and the United States. Lancet 269(6888):469\u2013474. https:\/\/doi.org\/10.1016\/s0140-6736(55)93328-6","journal-title":"Lancet"},{"issue":"9","key":"312_CR23","doi-asserted-by":"publisher","first-page":"4771","DOI":"10.1128\/JVI.02892-15","volume":"90","author":"R de Alwis","year":"2016","unstructured":"de Alwis R, Bangs DJ, Angelo MA, Cerpas C, Fernando A, Sidney J et al (2016) Immunodominant dengue virus-specific CD8+ T cell responses are associated with a memory PD-1+ phenotype. J Virol 90(9):4771\u20134779. https:\/\/doi.org\/10.1128\/JVI.02892-15","journal-title":"J Virol"},{"key":"312_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0003520","volume":"9","author":"AM de Matos","year":"2015","unstructured":"de Matos AM, Carvalho KI, Rosa DS, Villas-Boas LS, da Silva WC, Rodrigues CL, Oliveira OM, Levi JE, Araujo ES, Pannuti CS, Luna EJ, Kallas EG (2015) CD8+ T lymphocyte expansion, proliferation and activation in dengue fever. PLoS Negl Trop Dis 9:e0003520","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"312_CR25","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.jid.2017.10.018","volume":"138","author":"P Duangkhae","year":"2018","unstructured":"Duangkhae P, Erdos G, Ryman KD, Watkins SC, Falo LD Jr, Marques ETA Jr, Barratt-Boyes SM (2018) Interplay between keratinocytes and myeloid cells drives dengue virus spread in human skin. J Invest Dermatol 138(3):618\u2013626. https:\/\/doi.org\/10.1016\/j.jid.2017.10.018","journal-title":"J Invest Dermatol"},{"issue":"39","key":"312_CR26","doi-asserted-by":"publisher","first-page":"16922","DOI":"10.1073\/pnas.1010867107","volume":"107","author":"T Duangchinda","year":"2010","unstructured":"Duangchinda T, Dejnirattisai W, Vasanawathana S, Limpitikul W, Tangthawornchaikul N, Malasit P, Mongkolsapaya J, Screaton G (2010) Immunodominant T-cell responses to dengue virus NS3 are associated with DHF. Proc Natl Acad Sci USA 107(39):16922\u201316927. https:\/\/doi.org\/10.1073\/pnas.1010867107","journal-title":"Proc Natl Acad Sci USA"},{"key":"312_CR27","doi-asserted-by":"publisher","first-page":"7281","DOI":"10.4049\/jimmunol.0903262","volume":"184","author":"NTP Dung","year":"2010","unstructured":"Dung NTP, Duyen HTL, Thuy NTV, Ngoc TV, Chau NVV, Hien TT, Rowland-Jones SL, Dong T, Farrar J, Wills B, Simmons CP (2010) Timing of CD8+ T cell responses in relation to commencement of capillary leakage in children with dengue. J Immunol 184:7281\u20137287. https:\/\/doi.org\/10.4049\/jimmunol.0903262","journal-title":"J Immunol"},{"issue":"6","key":"312_CR28","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1093\/infdis\/jiw067","volume":"214","author":"AP Durbin","year":"2016","unstructured":"Durbin AP, Kirkpatrick BD, Pierce KK, Carmolli MP, Tibery CM, Grier PL, Hynes N, Opert K, Jarvis AP, Sabundayo BP, McElvany BD, Sendra EA, Larsson CJ, Jo M, Lovchik JM, Luke CJ, Walsh MC, Fraser EA, Subbarao K, Whitehead SS (2016) A 12-month-interval dosing study in adults indicates that a single dose of the National Institute of Allergy and Infectious Diseases tetravalent dengue vaccine induces a robust neutralizing antibody response. J Infect Dis 214(6):832\u2013835. https:\/\/doi.org\/10.1093\/infdis\/jiw067","journal-title":"J Infect Dis"},{"key":"312_CR29","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.ebiom.2016.10.006","volume":"13","author":"A Elong Ngono","year":"2016","unstructured":"Elong Ngono A, Chen HW, Tang WW, Joo Y, King K, Weiskopf D, Sidney J, Sette A, Shresta S (2016) Protective role of cross-reactive CD8 T cells against dengue virus infection. EBioMedicine 13:284\u2013293. https:\/\/doi.org\/10.1016\/j.ebiom.2016.10.006","journal-title":"EBioMedicine"},{"issue":"6","key":"312_CR30","first-page":"572","volume":"104","author":"T Francis Jr","year":"1960","unstructured":"Francis T Jr (1960) On the doctrine of original antigenic sin. Proc Am Philos Soc 104(6):572\u2013578","journal-title":"Proc Am Philos Soc"},{"key":"312_CR31","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/icb.2010.61","volume":"89","author":"H Friberg","year":"2011","unstructured":"Friberg H et al (2011a) Memory CD8(+) T cells from naturally acquired primary dengue virus infection are highly cross-reactive. Immunol Cell Biol 89:122\u2013129","journal-title":"Immunol Cell Biol"},{"key":"312_CR32","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/srep00051","volume":"1","author":"H Friberg","year":"2011","unstructured":"Friberg H, Bashyam H, Toyosaki-Maeda T, Potts JA, Greenough T, Kalayanarooj S, Gibbons RV, Nisalak A, Srikiatkhachorn A, Green S, Stephens HA, Rothman AL, Mathew A (2011b) Cross-reactivity and expansion of dengue-specific T cells during acute primary and secondary infections in humans. Sci Rep 1:51. https:\/\/doi.org\/10.1038\/srep00051","journal-title":"Sci Rep"},{"issue":"1","key":"312_CR33","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s41541-022-00537-2","volume":"7","author":"H Friberg","year":"2022","unstructured":"Friberg H, Gargulak M, Kong A, Lin L, Martinez LJ, Schmidt AC, Paris RM, Jarman RG, Diaz C, Thomas SJ, Moris P, Currier JR (2022) Characterization of B-cell and T-cell responses to a tetravalent dengue purified inactivated vaccine in healthy adults. NPJ Vaccines. 7(1):132. https:\/\/doi.org\/10.1038\/s41541-022-00537-2","journal-title":"NPJ Vaccines."},{"issue":"4","key":"312_CR34","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.179771","volume":"10","author":"RI G\u00e1lvez","year":"2025","unstructured":"G\u00e1lvez RI, Mart\u00ednez-P\u00e9rez A, Escarrega EA, Singh T, Zambrana JV, Balmaseda \u00c1, Harris E, Weiskopf D (2025) Frequency of dengue virus-specific T cells is related to infection outcome in endemic settings. JCI Insight 10(4):e179771. https:\/\/doi.org\/10.1172\/jci.insight.179771","journal-title":"JCI Insight"},{"issue":"7","key":"312_CR35","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1002\/eji.201948420","volume":"50","author":"JA George","year":"2020","unstructured":"George JA, Park SO, Choi JY, Uyangaa E, Eo SK (2020) Double-faced implication of CD4+ Foxp3+ regulatory T cells expanded by acute dengue infection via TLR2\/MyD88 pathway. Eur J Immunol 50(7):1000\u20131018. https:\/\/doi.org\/10.1002\/eji.201948420","journal-title":"Eur J Immunol"},{"issue":"12","key":"312_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0004277","volume":"9","author":"AJ Gon\u00e7alves","year":"2015","unstructured":"Gon\u00e7alves AJ, Oliveira ER, Costa SM, Paes MV, Silva JF, Azevedo AS, Mantuano-Barradas M, Nogueira AC, Almeida CJ, Alves AM (2015) Cooperation between CD4+ T cells and humoral immunity is critical for protection against dengue using a DNA vaccine based on the NS1 antigen. PLoS Negl Trop Dis 9(12):e0004277. https:\/\/doi.org\/10.1371\/journal.pntd.0004277","journal-title":"PLoS Negl Trop Dis"},{"issue":"4","key":"312_CR37","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1086\/314680","volume":"179","author":"S Green","year":"1999","unstructured":"Green S, Vaughn DW, Kalayanarooj S, Nimmannitya S, Suntayakorn S, Nisalak A, Lew R, Innis BL, Kurane I, Rothman AL, Ennis FA (1999) Early immune activation in acute dengue illness is related to development of plasma leakage and disease severity. J Infect Dis 179(4):755\u2013762. https:\/\/doi.org\/10.1086\/314680","journal-title":"J Infect Dis"},{"issue":"8","key":"312_CR38","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.3389\/fimmu.2017.01309","volume":"13","author":"A Grifoni","year":"2017","unstructured":"Grifoni A, Angelo MA, Lopez B, O'Rourke PH, Sidney J, Cerpas C, Balmaseda A, Silveira CGT, Maestri A, Costa PR, Durbin AP, Diehl SA, Phillips E, Mallal S, De Silva AD, Nchinda G, Nkenfou C, Collins MH, de Silva AM, Lim MQ, Macary PA, Tatullo F, Solomon T, Satchidanandam V, Desai A, Ravi V, Coloma J, Turtle L, Rivino L, Kallas EG, Peters B, Harris E, Sette A, Weiskopf D (2017) Global assessment of dengue virus-specific CD4+ T cell responses in dengue-endemic areas. Front Immunol 13(8):1309. https:\/\/doi.org\/10.3389\/fimmu.2017.01309","journal-title":"Front Immunol"},{"issue":"4","key":"312_CR39","doi-asserted-by":"publisher","first-page":"612","DOI":"10.3390\/vaccines10040612","volume":"10","author":"A Grifoni","year":"2022","unstructured":"Grifoni A, Voic H, Yu ED, Mateus J, Yan Fung KM, Wang A, Seumois G, De Silva AD, Tennekon R, Premawansa S, Premawansa G, Tippalagama R, Wijewickrama A, Chawla A, Greenbaum J, Peters B, Pandurangan V, Weiskopf D, Sette A (2022) Transcriptomics of acute DENV-specific CD8+ T cells does not support qualitative differences as drivers of disease severity. Vaccines (Basel) 10(4):612. https:\/\/doi.org\/10.3390\/vaccines10040612","journal-title":"Vaccines (Basel)"},{"issue":"6","key":"312_CR40","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1002\/eji.201243229","volume":"43","author":"R Guabiraba","year":"2013","unstructured":"Guabiraba R, Besnard AG, Marques RE, Maillet I, Fagundes CT, Concei\u00e7\u00e3o TM, Rust NM, Charreau S, Paris I, Lecron JC, Renauld JC, Quesniaux V, Da Poian AT, Arruda LB, Souza DG, Ryffel B, Teixeira MM (2013) IL-22 modulates IL-17A production and controls inflammation and tissue damage in experimental dengue infection. Eur J Immunol 43(6):1529\u20131544. https:\/\/doi.org\/10.1002\/eji.201243229","journal-title":"Eur J Immunol"},{"key":"312_CR41","doi-asserted-by":"publisher","first-page":"7290","DOI":"10.1128\/JVI.75.16.7290-7304.2001","volume":"75","author":"F Guirakhoo","year":"2001","unstructured":"Guirakhoo F, Arroyo J, Pugachev KV, Miller C, Zhang Z-X, Weltzin R, Georgakopoulos K, Catalan J, Ocran S, Soike K et al (2001) Construction, safety, and immunogenicity in nonhuman primates of a chimeric yellow fever-dengue virus tetravalent vaccine. J Virol 75:7290\u20137304","journal-title":"J Virol"},{"key":"312_CR42","doi-asserted-by":"publisher","first-page":"5712","DOI":"10.1016\/j.vaccine.2008.08.019","volume":"26","author":"B Guy","year":"2008","unstructured":"Guy B, Nougarede N, Begue S, Sanchez V, Souag N, Carre M et al (2008) Cell-mediated immunity induced by chimeric tetravalent dengue vaccine in naive or flavivirus-primed subjects. Vaccine 26:5712\u20135721. https:\/\/doi.org\/10.1016\/j.vaccine.2008.08.019","journal-title":"Vaccine"},{"issue":"50","key":"312_CR43","doi-asserted-by":"publisher","first-page":"7100","DOI":"10.1016\/j.vaccine.2015.09.108","volume":"33","author":"B Guy","year":"2015","unstructured":"Guy B, Briand O, Lang J, Saville M, Jackson N (2015) Development of the Sanofi Pasteur tetravalent dengue vaccine: one more step forward. Vaccine 33(50):7100\u20137111. https:\/\/doi.org\/10.1016\/j.vaccine.2015.09.108","journal-title":"Vaccine"},{"issue":"12 Suppl","key":"312_CR44","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1038\/nrmicro2460","volume":"8","author":"MG Guzman","year":"2010","unstructured":"Guzman MG, Halstead SB, Artsob H, Buchy P, Farrar J, Gubler DJ, Hunsperger E, Kroeger A, Margolis HS, Mart\u00ednez E, Nathan MB, Pelegrino JL, Simmons C, Yoksan S, Peeling RW (2010) Dengue: a continuing global threat. Nat Rev Microbiol 8(12 Suppl):S7\u2013S16. https:\/\/doi.org\/10.1038\/nrmicro2460","journal-title":"Nat Rev Microbiol"},{"key":"312_CR45","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1056\/NEJMoa1506223","volume":"373","author":"SR Hadinegoro","year":"2015","unstructured":"Hadinegoro SR, Arredondo-Garc\u00eda JL, Capeding MR, Deseda C, Chotpitayasunondh T, Dietze R, Hj Muhammad Ismail HI, Reynales H, Limkittikul K, Rivera-Medina DM et al (2015) Efficacy and long-term safety of a dengue vaccine in regions of endemic disease. N Engl J Med 373:1195\u20131206","journal-title":"N Engl J Med"},{"issue":"5","key":"312_CR46","first-page":"350","volume":"42","author":"SB Halstead","year":"1970","unstructured":"Halstead SB (1970) Observations related to pathogensis of dengue hemorrhagic fever. VI. Hypotheses and discussion. Yale J Biol Med 42(5):350\u2013362","journal-title":"Yale J Biol Med"},{"issue":"1","key":"312_CR47","doi-asserted-by":"publisher","first-page":"136","DOI":"10.3181\/00379727-151-39160","volume":"151","author":"SB Halstead","year":"1976","unstructured":"Halstead SB, Marchette NJ, Sung Chow JS, Lolekha S (1976) Dengue virus replication enhancement in peripheral blood leukocytes from immune human beings. Proc Soc Exp Biol Med 151(1):136\u2013139. https:\/\/doi.org\/10.3181\/00379727-151-39160","journal-title":"Proc Soc Exp Biol Med"},{"issue":"9599","key":"312_CR48","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1016\/S0140-6736(07)61687-0","volume":"370","author":"SB Halstead","year":"2007","unstructured":"Halstead SB (2007) Dengue Lancet 370(9599):1644\u20131652. https:\/\/doi.org\/10.1016\/S0140-6736(07)61687-0","journal-title":"Dengue Lancet"},{"issue":"10","key":"312_CR49","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1093\/infdis\/jiy360","volume":"218","author":"K Haltaufderhyde","year":"2018","unstructured":"Haltaufderhyde K, Srikiatkhachorn A, Green S, Macareo L, Park S, Kalayanarooj S, Rothman AL, Mathew A (2018) Activation of peripheral T follicular helper cells during acute dengue virus infection. J Infect Dis 218(10):1675\u20131685. https:\/\/doi.org\/10.1093\/infdis\/jiy360","journal-title":"J Infect Dis"},{"issue":"9","key":"312_CR50","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1093\/infdis\/jir012","volume":"203","author":"S Hatch","year":"2011","unstructured":"Hatch S, Endy TP, Thomas S, Mathew A, Potts J, Pazoles P, Libraty DH, Gibbons R, Rothman AL (2011) Intracellular cytokine production by dengue virus-specific T cells correlates with subclinical secondary infection. J Infect Dis 203(9):1282\u20131291. https:\/\/doi.org\/10.1093\/infdis\/jir012","journal-title":"J Infect Dis"},{"issue":"8","key":"312_CR51","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1111\/j.1348-0421.1996.tb01110.x","volume":"40","author":"D Hober","year":"1996","unstructured":"Hober D, Delannoy AS, Benyoucef S, De Groote D, Wattr\u00e9 P (1996) High levels of sTNFR p75 and TNF alpha in dengue-infected patients. Microbiol Immunol 40(8):569\u2013573. https:\/\/doi.org\/10.1111\/j.1348-0421.1996.tb01110.x","journal-title":"Microbiol Immunol"},{"issue":"1","key":"312_CR52","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41392-023-01653-8","volume":"8","author":"Y Hu","year":"2023","unstructured":"Hu Y, Hu Q, Li Y, Lu L, Xiang Z, Yin Z, Kabelitz D, Wu Y (2023) \u0393\u03b4 T cells: origin and fate, subsets, diseases and immunotherapy. Signal Transduct Target Ther 8(1):434. https:\/\/doi.org\/10.1038\/s41392-023-01653-8","journal-title":"Signal Transduct Target Ther"},{"key":"312_CR53","doi-asserted-by":"publisher","first-page":"11436","DOI":"10.1128\/jvi.77.21.11436-11447.2003","volume":"77","author":"CY-H Huang","year":"2003","unstructured":"Huang CY-H, Butrapet S, Tsuchiya KR et al (2003) Dengue 2 PDK-53 virus as a chimeric carrier for tetravalent dengue vaccine development. J Virol 77:11436\u201311447. https:\/\/doi.org\/10.1128\/jvi.77.21.11436-11447.2003","journal-title":"J Virol"},{"issue":"18","key":"312_CR54","doi-asserted-by":"publisher","first-page":"10081","DOI":"10.1128\/JVI.00330-07","volume":"81","author":"A Imrie","year":"2007","unstructured":"Imrie A, Meeks J, Gurary A, Sukhbataar M, Kitsutani P, Effler P, Zhao Z (2007) Differential functional avidity of dengue virus-specific T-cell clones for variant peptides representing heterologous and previously encountered serotypes. J Virol 81(18):10081\u201310091. https:\/\/doi.org\/10.1128\/JVI.00330-07","journal-title":"J Virol"},{"issue":"1","key":"312_CR55","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12929-023-00916-4","volume":"30","author":"LJ Ioannidis","year":"2023","unstructured":"Ioannidis LJ, Studniberg SI, Eriksson EM, Suwarto S, Denis D, Liao Y, Shi W, Garnham AL, Sasmono RT, Hansen DS (2023) Integrated systems immunology approach identifies impaired effector T cell memory responses as a feature of progression to severe dengue fever. J Biomed Sci 30(1):24. https:\/\/doi.org\/10.1186\/s12929-023-00916-4","journal-title":"J Biomed Sci"},{"issue":"1","key":"312_CR56","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/imm.12863","volume":"154","author":"HE Jayaratne","year":"2018","unstructured":"Jayaratne HE, Wijeratne D, Fernando S, Kamaladasa A, Gomes L, Wijewickrama A, Ogg GS, Malavige GN (2018) Regulatory T-cells in acute dengue viral infection. Immunology 154(1):89\u201397. https:\/\/doi.org\/10.1111\/imm.12863","journal-title":"Immunology"},{"issue":"4","key":"312_CR57","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0003673","volume":"9","author":"C Jeewandara","year":"2015","unstructured":"Jeewandara C, Adikari TN, Gomes L, Fernando S, Fernando RH, Perera MK, Ariyaratne D, Kamaladasa A, Salimi M, Prathapan S, Ogg GS, Malavige GN (2015) Functionality of dengue virus specific memory T cell responses in individuals who were hospitalized or who had mild or subclinical dengue infection. PLoS Negl Trop Dis 9(4):e0003673. https:\/\/doi.org\/10.1371\/journal.pntd.0003673","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"312_CR58","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1056\/NEJMoa2301790","volume":"390","author":"EG Kall\u00e1s","year":"2024","unstructured":"Kall\u00e1s EG, Cintra MAT, Moreira JA, Pati\u00f1o EG, Braga PE, Ten\u00f3rio JCV, Infante V, Palacios R, de Lacerda MVG, Batista Pereira D, da Fonseca AJ, Gurgel RQ, Coelho IC, Fontes CJF, Marques ETA, Romero GAS, Teixeira MM, Siqueira AM, Barral AMP, Boaventura VS, Ramos F, Elias J\u00fanior E, Cassio de Moraes J, Covas DT, Kalil J, Precioso AR, Whitehead SS, Esteves-Jaramillo A, Shekar T, Lee JJ, Macey J, Kelner SG, Coller BG, Boulos FC, Nogueira ML (2024) Live, attenuated, tetravalent Butantan-dengue vaccine in children and adults. N Engl J Med 390(5):397\u2013408. https:\/\/doi.org\/10.1056\/NEJMoa2301790","journal-title":"N Engl J Med"},{"issue":"2","key":"312_CR59","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.cellimm.2007.02.005","volume":"244","author":"AM Khan","year":"2006","unstructured":"Khan AM, Miotto O, Heiny AT, Salmon J, Srinivasan KN, Nascimento EJ, Marques ET Jr, Brusic V, Tan TW, August JT (2006) A systematic bioinformatics approach for selection of epitope-based vaccine targets. Cell Immunol 244(2):141\u2013147. https:\/\/doi.org\/10.1016\/j.cellimm.2007.02.005","journal-title":"Cell Immunol"},{"issue":"8","key":"312_CR60","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000272","volume":"2","author":"AM Khan","year":"2008","unstructured":"Khan AM, Miotto O, Nascimento EJ, Srinivasan KN, Heiny AT, Zhang GL, Marques ET, Tan TW, Brusic V, Salmon J, August JT (2008) Conservation and variability of dengue virus proteins: implications for vaccine design. PLoS Negl Trop Dis 2(8):e272. https:\/\/doi.org\/10.1371\/journal.pntd.0000272","journal-title":"PLoS Negl Trop Dis"},{"issue":"10","key":"312_CR61","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1016\/j.jiph.2023.08.001","volume":"16","author":"MB Khan","year":"2023","unstructured":"Khan MB, Yang ZS, Lin CY, Hsu MC, Urbina AN, Assavalapsakul W, Wang WH, Chen YH, Wang SF (2023) Dengue overview: An updated systemic review. J Infect Public Health 16(10):1625\u20131642. https:\/\/doi.org\/10.1016\/j.jiph.2023.08.001","journal-title":"J Infect Public Health"},{"issue":"5","key":"312_CR62","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1093\/infdis\/jiv082","volume":"212","author":"BD Kirkpatrick","year":"2015","unstructured":"Kirkpatrick BD, Durbin AP, Pierce KK, Carmolli MP, Tibery CM, Grier PL, Hynes N, Diehl SA, Elwood D, Jarvis AP, Sabundayo BP, Lyon CE, Larsson CJ, Jo M, Lovchik JM, Luke CJ, Walsh MC, Fraser EA, Subbarao K, Whitehead SS (2015) Robust and balanced immune responses to all 4 dengue virus serotypes following administration of a single dose of a live attenuated tetravalent dengue vaccine to healthy, flavivirus-naive adults. J Infect Dis 212(5):702\u2013710","journal-title":"J Infect Dis"},{"key":"312_CR63","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01861-24","volume":"31","author":"S Kumari","year":"2024","unstructured":"Kumari S, Biswas A, Maiti TK, Bandyopadhyay B, Banerjee A (2024) Induction of PD-1 and CD44 in CD4+ T cells by circulatory extracellular vesicles from severe dengue patients drives endothelial damage via the NF-kB signaling pathway. J Virol 31:e0186124. https:\/\/doi.org\/10.1128\/jvi.01861-24","journal-title":"J Virol"},{"issue":"3","key":"312_CR64","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1084\/jem.170.3.763","volume":"170","author":"I Kurane","year":"1989","unstructured":"Kurane I, Meager A, Ennis FA (1989) Dengue virus-specific human T cell clones. Serotype crossreactive proliferation, interferon gamma production, and cytotoxic activity. J Exp Med 170(3):763\u2013775. https:\/\/doi.org\/10.1084\/jem.170.3.763","journal-title":"J Exp Med"},{"issue":"4","key":"312_CR65","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1128\/JVI.65.4.1823-1828.1991","volume":"65","author":"I Kurane","year":"1991","unstructured":"Kurane I, Brinton MA, Samson AL, Ennis FA (1991a) Dengue virus-specific, human CD4+ CD8- cytotoxic T-cell clones: multiple patterns of virus cross-reactivity recognized by NS3-specific T-cell clones. J Virol 65(4):1823\u20131828. https:\/\/doi.org\/10.1128\/JVI.65.4.1823-1828.1991","journal-title":"J Virol"},{"issue":"5","key":"312_CR66","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1172\/JCI115457","volume":"88","author":"I Kurane","year":"1991","unstructured":"Kurane I, Innis BL, Nimmannitya S, Nisalak A, Meager A, Janus J, Ennis FA (1991b) Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue. J Clin Invest 88(5):1473\u20131480. https:\/\/doi.org\/10.1172\/JCI115457","journal-title":"J Clin Invest"},{"issue":"11","key":"312_CR67","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/s0198-8859(02)00682-1","volume":"63","author":"C LaFleur","year":"2002","unstructured":"LaFleur C, Granados J, Vargas-Alarcon G, Ru\u00edz-Morales J, Villarreal-Garza C, Higuera L, Hern\u00e1ndez-Pacheco G, Cuti\u00f1o-Moguel T, Rangel H, Figueroa R, Acosta M, Lazcano E, Ramos C (2002) HLA-DR antigen frequencies in Mexican patients with dengue virus infection: HLA-DR4 as a possible genetic resistance factor for dengue hemorrhagic fever. Hum Immunol 63(11):1039\u20131044. https:\/\/doi.org\/10.1016\/s0198-8859(02)00682-1","journal-title":"Hum Immunol"},{"issue":"4","key":"312_CR68","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.immuni.2013.08.031","volume":"39","author":"M Locci","year":"2013","unstructured":"Locci M, Havenar-Daughton C, Landais E, Wu J, Kroenke MA, Arlehamn CL, Su LF, Cubas R, Davis MM, Sette A, Haddad EK, International AIDS Vaccine Initiative Protocol C Principal Investigators, Poignard P, Crotty S (2013) Human circulating PD-1+CXCR3-CXCR5+ memory Tfh cells are highly functional and correlate with broadly neutralizing HIV antibody responses. Immunity 39(4):758\u2013769. https:\/\/doi.org\/10.1016\/j.immuni.2013.08.031","journal-title":"Immunity"},{"key":"312_CR69","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1084\/jem.20090247","volume":"206","author":"MP Longhi","year":"2009","unstructured":"Longhi MP et al (2009) Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant. J Exp Med 206:1589\u20131602","journal-title":"J Exp Med"},{"issue":"17\u201318","key":"312_CR70","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1016\/s0264-410x(03)00009-4","volume":"21","author":"Y Lu","year":"2003","unstructured":"Lu Y, Raviprakash K, Leao IC, Chikhlikar PR, Ewing D, Anwar A, Chougnet C, Murphy G, Hayes CG, August TJ, Marques ET Jr (2003) Dengue 2 PreM-E\/LAMP chimera targeted to the MHC class II compartment elicits long-lasting neutralizing antibodies. Vaccine 21(17\u201318):2178\u20132189. https:\/\/doi.org\/10.1016\/s0264-410x(03)00009-4","journal-title":"Vaccine"},{"key":"312_CR71","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1084\/jem.20061381","volume":"204","author":"K Luhn","year":"2007","unstructured":"Luhn K, Simmons CP, Moran E, Dung NT, Chau TN, Quyen NT et al (2007) Increased frequencies of CD4+ CD25(high) regulatory T-cells in acute dengue infection. J Exp Med 204:979\u2013985","journal-title":"J Exp Med"},{"issue":"1","key":"312_CR72","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/s41541-024-00967-0","volume":"9","author":"S Mandaric","year":"2024","unstructured":"Mandaric S, Friberg H, Saez-Llorens X, Borja-Tabora C, Biswal S, Escudero I, Faccin A, Gottardo R, Brose M, Roubinis N, Fladager D, DeAntonio R, Dimero JAL, Montenegro N, Folschweiller N, Currier JR, Sharma M, Tricou V (2024) Long term T cell response and safety of a tetravalent dengue vaccine in healthy children. NPJ Vaccines 9(1):192. https:\/\/doi.org\/10.1038\/s41541-024-00967-0","journal-title":"NPJ Vaccines"},{"issue":"4","key":"312_CR73","doi-asserted-by":"publisher","first-page":"2676","DOI":"10.4049\/jimmunol.175.4.2676","volume":"175","author":"MM Mangada","year":"2005","unstructured":"Mangada MM, Rothman AL (2005) Altered cytokine responses of dengue-specific CD4+ T cells to heterologous serotypes. J Immunol 175(4):2676\u20132683. https:\/\/doi.org\/10.4049\/jimmunol.175.4.2676","journal-title":"J Immunol"},{"issue":"3","key":"312_CR74","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1172\/JCI122530","volume":"129","author":"CK Mantri","year":"2019","unstructured":"Mantri CK, St John AL (2019) Immune synapses between mast cells and \u03b3\u03b4 T cells limit viral infection. J Clin Invest 129(3):1094\u20131108. https:\/\/doi.org\/10.1172\/JCI122530","journal-title":"J Clin Invest"},{"issue":"7","key":"312_CR75","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1172\/JCI118964","volume":"98","author":"A Mathew","year":"1996","unstructured":"Mathew A, Kurane I, Rothman AL, Zeng LL, Brinton MA, Ennis FA (1996) Dominant recognition by human CD8+ cytotoxic T lymphocytes of dengue virus nonstructural proteins NS3 and NS1.2a. J Clin Invest 98(7):1684\u20131691. https:\/\/doi.org\/10.1172\/JCI118964","journal-title":"J Clin Invest"},{"issue":"7","key":"312_CR76","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1038\/nm887","volume":"9","author":"J Mongkolsapaya","year":"2003","unstructured":"Mongkolsapaya J, Dejnirattisai W, Xu XN, Vasanawathana S, Tangthawornchaikul N, Chairunsri A, Sawasdivorn S, Duangchinda T, Dong T, Rowland-Jones S, Yenchitsomanus PT, McMichael A, Malasit P, Screaton G (2003) Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat Med 9(7):921\u2013927. https:\/\/doi.org\/10.1038\/nm887","journal-title":"Nat Med"},{"issue":"9","key":"312_CR77","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1080\/21645515.2019.1581536","volume":"15","author":"P Moris","year":"2019","unstructured":"Moris P, Bauer KM, Currier JR, Friberg H, Eckels KH, Esquilin IO, Gibbons RV, Innis BL, Jarman RG, Simasathien S, Sun P, Thomas SJ, Watanaveeradej V (2019) Cell-mediated immune responses to different formulations of a live-attenuated tetravalent dengue vaccine candidate in subjects living in dengue endemic and non-endemic regions. Hum Vaccin Immunother 15(9):2090\u20132105. https:\/\/doi.org\/10.1080\/21645515.2019.1581536","journal-title":"Hum Vaccin Immunother"},{"issue":"3","key":"312_CR78","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1086\/649916","volume":"201","author":"D Morrison","year":"2010","unstructured":"Morrison D, Legg TJ, Billings CW, Forrat R, Yoksan S, Lang J (2010) A novel tetravalent dengue vaccine is well tolerated and immunogenic against all 4 serotypes in flavivirus-naive adults. J Infect Dis 201(3):370\u2013377. https:\/\/doi.org\/10.1086\/649916","journal-title":"J Infect Dis"},{"key":"312_CR79","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0007892","volume":"4","author":"EJ Nascimento","year":"2009","unstructured":"Nascimento EJ, Braga-Neto U, Calzavara-Silva CE, Gomes AL, Abath FG, Brito CA, Cordeiro MT, Silva AM, Magalhaes C, Andrade R, Gil LH, Marques ET Jr (2009) Gene expression profiling during early acute febrile stage of dengue infection can predict the disease outcome. PLoS One 4:e7892","journal-title":"PLoS One"},{"issue":"10","key":"312_CR80","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002497","volume":"7","author":"EJ Nascimento","year":"2013","unstructured":"Nascimento EJ, Mailliard RB, Khan AM, Sidney J, Sette A, Guzman N, Paulaitis M, de Melo AB, Cordeiro MT, Gil LV, Lemonnier F, Rinaldo C, August JT, Marques ET Jr (2013) Identification of conserved and HLA promiscuous DENV3 T-cell epitopes. PLoS Negl Trop Dis 7(10):e2497. https:\/\/doi.org\/10.1371\/journal.pntd.0002497","journal-title":"PLoS Negl Trop Dis"},{"issue":"11","key":"312_CR81","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/S1473-3099(24)00376-1","volume":"24","author":"ML Nogueira","year":"2024","unstructured":"Nogueira ML, Cintra MAT, Moreira JA, Pati\u00f1o EG, Braga PE, Ten\u00f3rio JCV, de Oliveira Alves LB, Infante V, Silveira DHR, de Lacerda MVG, Pereira DB, da Fonseca AJ, Gurgel RQ, Coelho IC, Fontes CJF, Marques ETA, Romero GAS, Teixeira MM, Siqueira AM, Boaventura VS, Ramos F, J\u00fanior EE, de Moraes JC, Whitehead SS, Esteves-Jaramillo A, Shekar T, Lee JJ, Macey J, Kelner SG, Coller BG, Boulos FC, Kall\u00e1s EG (2024) Phase 3 Butantan-DV working group. Efficacy and safety of Butantan-DV in participants aged 2-59 years through an extended follow-up: results from a double-blind, randomised, placebo-controlled, phase 3, multicentre trial in Brazil. Lancet Infect Dis 24(11):1234\u20131244. https:\/\/doi.org\/10.1016\/S1473-3099(24)00376-1","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"312_CR82","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/sj.icb.7100008","volume":"85","author":"T Pang","year":"2007","unstructured":"Pang T, Cardosa MJ, Guzman MG (2007) Of cascades and perfect storms: the immunopathogenesis of dengue haemorrhagic fever-dengue shock syndrome (DHF\/DSS). Immunol Cell Biol 85(1):43\u201345. https:\/\/doi.org\/10.1038\/sj.icb.7100008","journal-title":"Immunol Cell Biol"},{"issue":"2","key":"312_CR83","doi-asserted-by":"publisher","first-page":"2254964","DOI":"10.1080\/21645515.2023.2254964","volume":"19","author":"SS Patel","year":"2023","unstructured":"Patel SS, Winkle P, Faccin A, Nordio F, LeFevre I, Tsoukas CG (2023) An open-label, phase 3 trial of TAK-003, a live attenuated dengue tetravalent vaccine, in healthy US adults: immunogenicity and safety when administered during the second half of a 24-month shelf-life. Hum Vaccin Immunother 19(2):2254964. https:\/\/doi.org\/10.1080\/21645515.2023.2254964","journal-title":"Hum Vaccin Immunother"},{"issue":"9","key":"312_CR84","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1093\/infdis\/jiy053","volume":"217","author":"F Perdomo-Celis","year":"2018","unstructured":"Perdomo-Celis F, Romero F, Salgado DM, Vega R, Rodr\u00edguez J, Angel J, Franco MA, Greenberg HB, Narv\u00e1ez CF (2018) Identification and characterization at the single-cell level of cytokine-producing circulating cells in children with dengue. J Infect Dis 217(9):1472\u20131480. https:\/\/doi.org\/10.1093\/infdis\/jiy053","journal-title":"J Infect Dis"},{"issue":"1","key":"312_CR85","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0006191","volume":"12","author":"V Ramasamy","year":"2018","unstructured":"Ramasamy V, Arora U, Shukla R, Poddar A, Shanmugam RK, White LJ et al (2018) A tetravalent virus-like particle vaccine designed to display domain III of dengue envelope proteins induces multi-serotype neutralizing antibodies in mice and macaques which confer protection against antibody dependent enhancement in AG129 mice. PLoS Negl Trop Dis 12(1):e0006191. https:\/\/doi.org\/10.1371\/journal.pntd.0006191","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"312_CR86","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1006\/viro.2001.1136","volume":"290","author":"K Raviprakash","year":"2001","unstructured":"Raviprakash K, Marques E, Ewing D, Lu Y, Phillips I, Porter KR, Kochel TJ, August TJ, Hayes CG, Murphy GS (2001) Synergistic neutralizing antibody response to a dengue virus type 2 DNA vaccine by incorporation of lysosome-associated membrane protein sequences and use of plasmid expressing GM-CSF. Virology 290(1):74\u201382. https:\/\/doi.org\/10.1006\/viro.2001.1136","journal-title":"Virology"},{"issue":"1","key":"312_CR87","doi-asserted-by":"publisher","first-page":"7709","DOI":"10.1038\/s41598-024-57645-3","volume":"14","author":"LR Reis","year":"2024","unstructured":"Reis LR, Costa-Rocha IA, Abdala-Torres T, Campi-Azevedo AC, Peruhype-Magalh\u00e3es V, MSS A, Spezialli E, do Valle Antonelli LR, da Silva-Pereira RA, Almeida GG, Fernandes EG, Fantinato FFST, CMAS D, MCF L, Chieppe A, JAC L, Coelho-Dos-Reis JG, de Lima SMB, de Souza Azevedo A, Schwarcz WD, Camacho LAB, de Lourdes de Sousa Maia M, de Noronha TG, Duault C, Rosenberg-Hasson Y, Teixeira-Carvalho A, Maecker HT, Martins-Filho OA, Collaborative Group for Studies of Yellow Fever Vaccine (2024) Comprehensive landscape of neutralizing antibody and cell-mediated response elicited by the 1\/5 fractional dose of 17DD-YF primary vaccination in adults. Sci Rep 14(1):7709. https:\/\/doi.org\/10.1038\/s41598-024-57645-3","journal-title":"Sci Rep"},{"issue":"9","key":"312_CR88","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/ni.1923","volume":"11","author":"D Ricklin","year":"2010","unstructured":"Ricklin D, Hajishengallis G, Yang K, Lambris JD (2010) Complement: a key system for immune surveillance and homeostasis. Nat Immunol 11(9):785\u2013797. https:\/\/doi.org\/10.1038\/ni.1923","journal-title":"Nat Immunol"},{"key":"312_CR89","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1093\/cid\/ciab864","volume":"75","author":"L Rivera","year":"2022","unstructured":"Rivera L et al (2022) Three-year efficacy and safety of Takeda\u2019s dengue vaccine candidate (TAK-003). Clin Infect Dis 75:107\u2013117","journal-title":"Clin Infect Dis"},{"issue":"5","key":"312_CR90","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1128\/JVI.02675-12","volume":"87","author":"L Rivino","year":"2013","unstructured":"Rivino L, Kumaran EA, Jovanovic V, Nadua K, Teo EW, Pang SW, Teo GH, Gan VC, Lye DC, Leo YS, Hanson BJ, Smith KG, Bertoletti A, Kemeny DM, MacAry PA (2013) Differential targeting of viral components by CD4+ versus CD8+ T lymphocytes in dengue virus infection. J Virol 87(5):2693\u20132706. https:\/\/doi.org\/10.1128\/JVI.02675-12","journal-title":"J Virol"},{"key":"312_CR91","doi-asserted-by":"publisher","first-page":"278ra35","DOI":"10.1126\/scitranslmed.aaa0526","volume":"7","author":"L Rivino","year":"2015","unstructured":"Rivino L, Kumaran EA, Thein TL, Too CT, Gan VCH, Hanson BJ, Wilder-Smith A, Bertoletti A, Gascoigne NRJ, Lye DC et al (2015) Virus-specific T lymphocytes home to the skin during natural dengue infection. Sci Transl Med 7:278ra35","journal-title":"Sci Transl Med"},{"issue":"6","key":"312_CR92","doi-asserted-by":"publisher","first-page":"3385","DOI":"10.1128\/JVI.66.6.3385-3390.1992","volume":"66","author":"JT Roehrig","year":"1992","unstructured":"Roehrig JT, Johnson AJ, Hunt AR, Beaty BJ, Mathews JH (1992) Enhancement of the antibody response to flavivirus B-cell epitopes by using homologous or heterologous T-cell epitopes. J Virol 66(6):3385\u20133390. https:\/\/doi.org\/10.1128\/JVI.66.6.3385-3390.1992","journal-title":"J Virol"},{"key":"312_CR93","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1006\/viro.1999.9656","volume":"257","author":"AL Rothman","year":"1999","unstructured":"Rothman AL, Ennis FA (1999) Immunopathogenesis of dengue hemorrhagic fever. Virology 257:1\u20136","journal-title":"Virology"},{"issue":"5","key":"312_CR94","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2021.100278","volume":"2","author":"A Rouers","year":"2021","unstructured":"Rouers A, Chng MHY, Lee B, Rajapakse MP, Kaur K, Toh YX, Sathiakumar D, Loy T, Thein TL, Lim VWX, Singhal A, Yeo TW, Leo YS, Vora KA, Casimiro D, Lim B, Tucker-Kellogg L, Rivino L, Newell EW, Fink K (2021) Immune cell phenotypes associated with disease severity and long-term neutralizing antibody titers after natural dengue virus infection. Cell Rep Med 2(5):100278. https:\/\/doi.org\/10.1016\/j.xcrm.2021.100278","journal-title":"Cell Rep Med"},{"issue":"1","key":"312_CR95","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s12985-020-01449-0","volume":"17","author":"A Sabbaghi","year":"2020","unstructured":"Sabbaghi A, Miri SM, Keshavarz M, Mahooti M, Zebardast A, Ghaemi A (2020) Role of \u03b3\u03b4 T cells in controlling viral infections with a focus on influenza virus: implications for designing novel therapeutic approaches. Virol J 17(1):174. https:\/\/doi.org\/10.1186\/s12985-020-01449-0. PMID: 33183352","journal-title":"Virol J"},{"key":"312_CR96","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.3390\/v12121435","volume":"12","author":"LA S\u00e1nchez-Vargas","year":"2020","unstructured":"S\u00e1nchez-Vargas LA, Hern\u00e1ndez-Flores KG, Thomas-Dupont P, Izaguirre-Hern\u00e1ndez IY, S\u00e1nchez-Marce EE, Remes-Ruiz R, Fonseca-Coronado S, Hern\u00e1ndez-Romano PA, Flores-Collins ME, Vivanco-Cid H (2020) Characterization of the IL-17 and CD4+ Th17 cells in the clinical course of dengue virus infections. Viruses 12:1435","journal-title":"Viruses"},{"issue":"12","key":"312_CR97","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.710300","volume":"28","author":"LA Sanchez-Vargas","year":"2021","unstructured":"Sanchez-Vargas LA, Anderson KB, Srikiatkhachorn A, Currier JR, Friberg H, Endy TP, Fernandez S, Mathew A, Rothman AL (2021) Longitudinal analysis of dengue virus-specific memory T cell responses and their association with clinical outcome in subsequent DENV infection. Front Immunol 28(12):710300. https:\/\/doi.org\/10.3389\/fimmu.2021.710300","journal-title":"Front Immunol"},{"issue":"6","key":"312_CR98","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.00063-24","volume":"15","author":"S Sann","year":"2024","unstructured":"Sann S, Heng B, Vo HTM, Arroyo Hornero R, Lay S, Sorn S, Ken S, Ou TP, Laurent D, Yay C, Ly S, Dussart P, Duong V, Sakuntabhai A, Kleinewietfeld M, Cantaert T (2024) Increased frequencies of highly activated regulatory T cells skewed to a T helper 1-like phenotype with reduced suppressive capacity in dengue patients. mBio 15(6):e0006324. https:\/\/doi.org\/10.1128\/mbio.00063-24","journal-title":"mBio"},{"key":"312_CR99","doi-asserted-by":"publisher","first-page":"eaar4297","DOI":"10.1126\/sciadv.aar4297","volume":"4","author":"WAA Saron","year":"2018","unstructured":"Saron WAA et al (2018) Flavivirus serocomplex cross-reactive immunity is protective by activating heterologous memory CD4 T cells. Sci Adv 4:eaar4297","journal-title":"Sci Adv"},{"issue":"10","key":"312_CR100","doi-asserted-by":"publisher","first-page":"e02181","DOI":"10.1128\/JVI.02181-17","volume":"92","author":"GF Silveira","year":"2018","unstructured":"Silveira GF, Wowk PF, Cataneo AHD, Dos Santos PF, Delgobo M, Stimamiglio MA, Lo Sarzi M, Thomazelli APFS, Conchon-Costa I, Pavanelli WR, Antonelli LRV, B\u00e1fica A, Mansur DS, Dos Santos CND, Bordignon J (2018) Human T lymphocytes are permissive for dengue virus replication. J Virol 92(10):e02181\u2013e02117. https:\/\/doi.org\/10.1128\/JVI.02181-17","journal-title":"J Virol"},{"issue":"11","key":"312_CR101","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00746-23","volume":"97","author":"P Singh","year":"2023","unstructured":"Singh P, Bajpai P, Maheshwari D, Chawla YM, Saini K, Reddy ES, Gottimukkala K, Nayak K, Gunisetty S, Aggarwal C, Jain S, Verma C, Singla P, Soneja M, Wig N, Murali-Krishna K, Chandele A (2023) Functional and transcriptional heterogeneity within the massively expanding HLADR+CD38+ CD8 T cell population in acute febrile dengue patients. J Virol 97(11):e0074623. https:\/\/doi.org\/10.1128\/jvi.00746-23","journal-title":"J Virol"},{"issue":"11","key":"312_CR102","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1038\/s41590-018-0210-3","volume":"19","author":"JL Slon Campos","year":"2018","unstructured":"Slon Campos JL, Mongkolsapaya J, Screaton GR (2018) The immune response against flaviviruses. Nat Immunol 19(11):1189\u20131198. https:\/\/doi.org\/10.1038\/s41590-018-0210-3","journal-title":"Nat Immunol"},{"issue":"11","key":"312_CR103","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006738","volume":"13","author":"JK Sprokholt","year":"2017","unstructured":"Sprokholt JK, Kaptein TM, van Hamme JL, Overmars RJ, Gringhuis SI, Geijtenbeek TBH (2017) RIG-I-like receptor activation by dengue virus drives follicular T helper cell formation and antibody production. PLoS Pathog 13(11):e1006738. https:\/\/doi.org\/10.1371\/journal.ppat.1006738","journal-title":"PLoS Pathog"},{"key":"312_CR104","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1056\/NEJMoa1800820","volume":"379","author":"S Sridhar","year":"2018","unstructured":"Sridhar S, Luedtke A, Langevin E et al (2018) Effect of dengue serostatus on dengue vaccine safety and efficacy. N Engl J Med 379:327\u2013340","journal-title":"N Engl J Med"},{"issue":"51","key":"312_CR105","doi-asserted-by":"publisher","first-page":"7510","DOI":"10.1016\/j.vaccine.2021.10.017","volume":"39","author":"P Sun","year":"2021","unstructured":"Sun P, Jani V, Johnson A, Cheng Y, Nagabhushana N, Williams M, Morrison BJ, Defang G (2021) T cell and memory B cell responses in tetravalent DNA, tetravalent inactivated and tetravalent live-attenuated prime-boost dengue vaccines in rhesus macaques. Vaccine 39(51):7510\u20137520. https:\/\/doi.org\/10.1016\/j.vaccine.2021.10.017","journal-title":"Vaccine"},{"issue":"9","key":"312_CR106","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0006817","volume":"12","author":"J Suppiah","year":"2018","unstructured":"Suppiah J, Ching SM, Amin-Nordin S, Mat-Nor LA, Ahmad-Najimudin NA, Low GK, Abdul-Wahid MZ, Thayan R, Chee HY (2018) Clinical manifestations of dengue in relation to dengue serotype and genotype in Malaysia: a retrospective observational study. PLoS Negl Trop Dis 12(9):e0006817. https:\/\/doi.org\/10.1371\/journal.pntd.0006817","journal-title":"PLoS Negl Trop Dis"},{"key":"312_CR107","doi-asserted-by":"publisher","first-page":"531","DOI":"10.3389\/fimmu.2016.00531","volume":"7","author":"Y Tian","year":"2016","unstructured":"Tian Y, Sette A, Weiskopf D (2016) Cytotoxic CD4 T cells: differentiation, function, and application to dengue virus infection. Front Immunol 7:531. https:\/\/doi.org\/10.3389\/fimmu.2016.00531","journal-title":"Front Immunol"},{"issue":"10","key":"312_CR108","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.3389\/fimmu.2019.02125","volume":"4","author":"Y Tian","year":"2019","unstructured":"Tian Y, Grifoni A, Sette A, Weiskopf D (2019a) Human T cell response to dengue virus infection. Front Immunol 4(10):2125. https:\/\/doi.org\/10.3389\/fimmu.2019.02125","journal-title":"Front Immunol"},{"issue":"13","key":"312_CR109","doi-asserted-by":"publisher","first-page":"4482","DOI":"10.1016\/j.celrep.2019.11.098","volume":"29","author":"Y Tian","year":"2019","unstructured":"Tian Y, Seumois G, De-Oliveira-Pinto LM, Mateus J, Herrera-de la Mata S, Kim C, Hinz D, Goonawardhana NDS, de Silva AD, Premawansa S, Premawansa G, Wijewickrama A, Balmaseda A, Grifoni A, Vijayanand P, Harris E, Peters B, Sette A, Weiskopf D (2019b) Molecular signatures of dengue virus-specific IL-10\/IFN-\u03b3 co-producing CD4 T cells and their association with dengue disease. Cell Rep 29(13):4482\u20134495.e4. https:\/\/doi.org\/10.1016\/j.celrep.2019.11.098","journal-title":"Cell Rep"},{"issue":"11","key":"312_CR110","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/1471-2334-11-209","volume":"2","author":"T Tolfvenstam","year":"2011","unstructured":"Tolfvenstam T, Lindblom A, Schreiber MJ, Ling L, Chow A, Ooi EE, Hibberd ML (2011) Characterization of early host responses in adults with dengue disease. BMC Infect Dis 2(11):209. https:\/\/doi.org\/10.1186\/1471-2334-11-209","journal-title":"BMC Infect Dis"},{"issue":"8","key":"312_CR111","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/j.vaccine.2022.01.016","volume":"40","author":"V Tricou","year":"2022","unstructured":"Tricou V, Gottardo R, Egan MA, Clement F, Leroux-Roels G, S\u00e1ez-Llorens X, Borkowski A, Wallace D, Dean HJ (2022) Characterization of the cell-mediated immune response to Takeda's live-attenuated tetravalent dengue vaccine in adolescents participating in a phase 2 randomized controlled trial conducted in a dengue-endemic setting. Vaccine 40(8):1143\u20131151. https:\/\/doi.org\/10.1016\/j.vaccine.2022.01.016","journal-title":"Vaccine"},{"issue":"2","key":"312_CR112","doi-asserted-by":"publisher","first-page":"e257","DOI":"10.1016\/S2214-109X(23)00522-3","volume":"12","author":"V Tricou","year":"2024","unstructured":"Tricou V, Yu D, Reynales H, Biswal S, Saez-Llorens X, Sirivichayakul C, Lopez P, Borja-Tabora C, Bravo L, Kosalaraksa P, Vargas LM, Alera MT, Rivera L, Watanaveeradej V, Dietze R, Fernando L, Wickramasinghe VP, Moreira ED Jr, Fernando AD, Gunasekera D, Luz K, Oliveira AL, Tuboi S, Escudero I, Hutagalung Y, Lloyd E, Rauscher M, Zent O, Folschweiller N, LeFevre I, Espinoza F, Wallace D (2024) Long-term efficacy and safety of a tetravalent dengue vaccine (TAK-003): 4\u00b75-year results from a phase 3, randomised, double-blind, placebo-controlled trial. Lancet Glob Health 12(2):e257\u2013e270. https:\/\/doi.org\/10.1016\/S2214-109X(23)00522-3","journal-title":"Lancet Glob Health"},{"issue":"8","key":"312_CR113","doi-asserted-by":"publisher","first-page":"3890","DOI":"10.4049\/jimmunol.1303343","volume":"194","author":"CY Tsai","year":"2015","unstructured":"Tsai CY, Liong KH, Gunalan MG, Li N, Lim DS, Fisher DA, MacAry PA, Leo YS, Wong SC, Puan KJ, Wong SB (2015) Type I IFNs and IL-18 regulate the antiviral response of primary human \u03b3\u03b4 T cells against dendritic cells infected with dengue virus. J Immunol 194(8):3890\u20133900. https:\/\/doi.org\/10.4049\/jimmunol.1303343","journal-title":"J Immunol"},{"issue":"1","key":"312_CR114","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.imlet.2014.05.006","volume":"161","author":"H Vivanco-Cid","year":"2014","unstructured":"Vivanco-Cid H, Maldonado-Renteria MJ, Sanchez-Vargas LA, Izaguirre-Hernandez IY, Hernandez-Flores KG, Remes-Ruiz R (2014) Dynamics of interleukin-21 production during the clinical course of primary and secondary dengue virus infections. Immunol Lett 161(1):89\u201395. https:\/\/doi.org\/10.1016\/j.imlet.2014.05.006","journal-title":"Immunol Lett"},{"issue":"22","key":"312_CR115","doi-asserted-by":"publisher","first-page":"E2046","DOI":"10.1073\/pnas.1305227110","volume":"110","author":"D Weiskopf","year":"2013","unstructured":"Weiskopf D, Angelo MA, de Azeredo EL, Sidney J, Greenbaum JA, Fernando AN, Broadwater A, Kolla RV, De Silva AD, de Silva AM, Mattia KA, Doranz BJ, Grey HM, Shresta S, Peters B, Sette A (2013) Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells. Proc Natl Acad Sci USA 110(22):E2046\u2013E2053. https:\/\/doi.org\/10.1073\/pnas.1305227110","journal-title":"Proc Natl Acad Sci USA"},{"issue":"31","key":"312_CR116","doi-asserted-by":"publisher","first-page":"E4256","DOI":"10.1073\/pnas.1505956112","volume":"112","author":"D Weiskopf","year":"2015","unstructured":"Weiskopf D, Bangs DJ, Sidney J, Kolla RV, De Silva AD, de Silva AM, Crotty S, Peters B, Sette A (2015a) Dengue virus infection elicits highly polarized CX3CR1+ cytotoxic CD4+ T cells associated with protective immunity. Proc Natl Acad Sci USA 112(31):E4256\u2013E4263. https:\/\/doi.org\/10.1073\/pnas.1505956112","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"312_CR117","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1128\/JVI.02129-14","volume":"89","author":"D Weiskopf","year":"2015","unstructured":"Weiskopf D, Angelo MA, Bangs DJ, Sidney J, Paul S, Peters B, de Silva AD, Lindow JC, Diehl SA, Whitehead S, Durbin A, Kirkpatrick B, Sette A (2015b) The human CD8+ T cell responses induced by a live attenuated tetravalent dengue vaccine are directed against highly conserved epitopes. J Virol 89(1):120\u2013128. https:\/\/doi.org\/10.1128\/JVI.02129-14","journal-title":"J Virol"},{"issue":"7","key":"312_CR118","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1093\/infdis\/jiw309","volume":"214","author":"D Weiskopf","year":"2016","unstructured":"Weiskopf D, Angelo MA, Grifoni A, O'Rourke PH, Sidney J, Paul S, De Silva AD, Phillips E, Mallal S, Premawansa S, Premawansa G, Wijewickrama A, Peters B, Sette A (2016) HLA-DRB1 alleles are associated with different magnitudes of dengue virus-specific CD4+ T-cell responses. J Infect Dis 214(7):1117\u20131124. https:\/\/doi.org\/10.1093\/infdis\/jiw309","journal-title":"J Infect Dis"},{"key":"312_CR119","unstructured":"WHO (2024). https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/dengue-and-severe-dengue"},{"issue":"10","key":"312_CR120","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0006540","volume":"12","author":"DT Wijeratne","year":"2018","unstructured":"Wijeratne DT, Fernando S, Gomes L, Jeewandara C, Ginneliya A, Samarasekara S, Wijewickrama A, Hardman CS, Ogg GS, Malavige GN (2018) Quantification of dengue virus specific T cell responses and correlation with viral load and clinical disease severity in acute dengue infection. PLoS Negl Trop Dis 12(10):e0006540. https:\/\/doi.org\/10.1371\/journal.pntd.0006540","journal-title":"PLoS Negl Trop Dis"},{"issue":"7","key":"312_CR121","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/77553","volume":"6","author":"SJ Wu","year":"2000","unstructured":"Wu SJ, Grouard-Vogel G, Sun W, Mascola JR, Brachtel E, Putvatana R, Louder MK, Filgueira L, Marovich MA, Wong HK, Blauvelt A, Murphy GS, Robb ML, Innes BL, Birx DL, Hayes CG, Frankel SS (2000) Human skin Langerhans cells are targets of dengue virus infection. Nat Med 6(7):816\u2013820. https:\/\/doi.org\/10.1038\/77553","journal-title":"Nat Med"},{"issue":"8","key":"312_CR122","doi-asserted-by":"publisher","first-page":"4865","DOI":"10.4049\/jimmunol.0801974","volume":"182","author":"LE Yauch","year":"2009","unstructured":"Yauch LE, Zellweger RM, Kotturi MF, Qutubuddin A, Sidney J, Peters B, Prestwood TR, Sette A, Shresta S (2009) A protective role for dengue virus-specific CD8+ T cells. J Immunol 182(8):4865\u20134873. https:\/\/doi.org\/10.4049\/jimmunol.0801974","journal-title":"J Immunol"},{"key":"312_CR123","doi-asserted-by":"publisher","first-page":"5405","DOI":"10.4049\/jimmunol.1001709","volume":"185","author":"LE Yauch","year":"2010","unstructured":"Yauch LE et al (2010) CD4+ T cells are not required for the induction of dengue virus-specific CD8+ T cell or antibody responses but contribute to protection after vaccination. J Immunol 185:5405\u20135416","journal-title":"J Immunol"},{"issue":"5","key":"312_CR124","doi-asserted-by":"publisher","first-page":"999","DOI":"10.4269\/ajtmh.14-0628","volume":"92","author":"CF Yung","year":"2015","unstructured":"Yung CF, Lee KS, Thein TL, Tan LK, Gan VC, Wong JGX, Lye DC, Ng LC, Leo YS (2015) Dengue serotype-specific differences in clinical manifestation, laboratory parameters and risk of severe disease in adults, Singapore. Am J Trop Med Hyg 92(5):999\u20131005. https:\/\/doi.org\/10.4269\/ajtmh.14-0628","journal-title":"Am J Trop Med Hyg"},{"key":"312_CR125","doi-asserted-by":"publisher","first-page":"5959","DOI":"10.4049\/jimmunol.168.11.5959","volume":"168","author":"I Zivna","year":"2002","unstructured":"Zivna I et al (2002) T cell responses to an HLA-B*07-restricted epitope on the dengue NS3 protein correlate with disease severity. J Immunol 168:5959\u20135965","journal-title":"J Immunol"},{"issue":"5","key":"312_CR126","doi-asserted-by":"publisher","first-page":"2754","DOI":"10.4049\/jimmunol.163.5.2754","volume":"163","author":"J Zivny","year":"1999","unstructured":"Zivny J, DeFronzo M, Jarry W, Jameson J, Cruz J, Ennis FA, Rothman AL (1999) Partial agonist effect influences the CTL response to a heterologous dengue virus serotype. J Immunol 163(5):2754\u20132760","journal-title":"J Immunol"}],"container-title":["Current Topics in Microbiology and Immunology","Dengue Virus Evolution: From Emergence to a Global Health Crisis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/82_2025_312","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T23:21:23Z","timestamp":1767309683000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/82_2025_312"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9783032099808","9783032099815"],"references-count":126,"URL":"https:\/\/doi.org\/10.1007\/82_2025_312","relation":{},"ISSN":["0070-217X","2196-9965"],"issn-type":[{"type":"print","value":"0070-217X"},{"type":"electronic","value":"2196-9965"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"6 June 2025","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}